๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Significance of surgical adjuvant chemotherapy for gastric cancer

โœ Scribed by Nobuhiko Tanigawa; Hideki Morimoto


Publisher
John Wiley and Sons
Year
1991
Tongue
English
Weight
468 KB
Volume
46
Category
Article
ISSN
0022-4790

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Adjuvant chemotherapy for resectable gas
โœ Fong-Fu Chou; Shyr-Ming Sheen-Chen; Po-Pen Liu; Feng-Chi Chen ๐Ÿ“‚ Article ๐Ÿ“… 1994 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 295 KB

In this prospectively random study, the effect of oral Ftorafur as an adjuvant Chemotherapy was compared with that of oral placebo in patients with Stage I1 and Stage I11 gastric cancer. Patients had undergone a subtotal gastrectomy with a resection margin that should have been free of tumors. Ftora

Controlled trial of adjuvant chemotherap
โœ D. M. Stablein; H. O. Douglass Jr. ๐Ÿ“‚ Article ๐Ÿ“… 1982 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 584 KB

Following curative resection for gastric adenocarcinoma, 142 patients were randomized to receive adjuvant chemotherapy of methyl-CCNU and 5-FU or to be closely followed without chemotherapy. The median patient has been followed for four years. At the present time, there have been 38 recurrences and

Dose intensity of mitomycin C in adjuvan
โœ Tetsuro Kubota; Koichiro Kumai; Masaki Kitajima; Osahiko Abe; Masato Fujisaki; Y ๐Ÿ“‚ Article ๐Ÿ“… 1994 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 521 KB

Using a cohort of macroscopic curative resections of gastric cancer at stages 11, Ill, and IV, a randomized controlled trial was performed to clucidate the dose efficacy of intensive adjuvant cancer chemotherapy with mitomycin C. Between June 1983 and December 1986, 336 patients with gastric cancer

A prospective, randomized evaluation of
โœ James E. Krook; Michael J. O';Connell; Harry S. Wieand; Robert W. Beart Jr; John ๐Ÿ“‚ Article ๐Ÿ“… 1991 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 447 KB ๐Ÿ‘ 1 views

This study evaluated combined 5-fluorouracil(5FU) and doxorubicin as postoperative adjuvant chemotherapy for patients who had undergone potentially curative resection of a primary gastric adenocarcinoma. One hundred twenty-five eligible and evaluable patients were stratified according to extent of s